Company: MDCXW
Filing Date: 2025-03-07
Form Type: 253G1
Source: 0001062993-25-004966
Chunk: 220

Company: Medicus Pharma Ltd.
Filing Date: 2025-03-07
Form: 253G1
Chunk 220
---
 |   |     |     150,000 |   |
| Common shares issued                             |     4 |     | 1,277,488 |     |     5,109,950 |     |           - |     | -           |   |     |   5,109,950 |   |
| Share-based compensation                         |     9 |     |         - |     |             - |     |     146,671 |     | -           |   |     |     146,671 |   |
| Net loss and comprehensive loss for the year     |       |     |         - |     |             - |     |           - |     | (6,478,492  | ) |     |  (6,478,492 | ) |
| Balance as at December 31, 2023                  |       |     | 8,076,735 |     |    19,835,839 |     |     146,671 |     | (18,871,062 | ) |     |   1,111,448 |   |
| Balance as at December 31, 2021                  |       |     | 1,884,900 |     |       194,538 |     |           - |     | (10,700,188 | ) |     | (10,505,650 | ) |
| Net loss and comprehensive loss for the year     |       |     |         - |     |             - |     |           - |     | (1,692,382  | ) |     |  (1,692,382 | ) |
| Balance as at December 31, 2022                  |       |     | 1,884,900 |     |       194,538 |     |           - |     | (12,392,570 | ) |     | (12,198,032 | ) |

The accompanying notes are an integral part of these consolidated financial statements.

<div align='center'>F-25

Medicus Pharma Ltd.

Consolidated Statements of Cash Flows

(expressed in United States dollars)</div>

|                                                        |     |       2023 |   |     | For the years ended December 31, 
                             2022 |   |
|:-------------------------------------------------------|:----|-----------:|:--|:----|---------------------------------:|:--|
|                                                        |     |          $ |   |     |                                $ |